Literature DB >> 27411685

[Treatment of dermatoses : Significance and use of glucocorticoids in fixed combination with antifungals].

P Mayser1.   

Abstract

Treating eczema with fungal and/or bacterial superinfections or superficial mycoses are a common problem in daily practice. A fungal superinfection as a consequence of a diminished skin barrier might complicate the course of eczema. In addition, in an inflammatory superficial mycotic infection a delayed-type hypersensitivity reaction may result in healing of the lesion, but might also be responsible for irreversible damage of epidermal structures. An example is permanent hair loss by scarring alopecia in the context of inflammatory tinea capitis. In both cases, combination of an antifungal and a glucocorticoid is appropriate in therapy, preferentially in topical application. The use of azole antimycotics is especially helpful, as they are also effective against gram-positive bacteria.

Entities:  

Keywords:  Administration, cutaneous; Combination therapy; Eczema; Mycoses; Tinea capitis

Mesh:

Substances:

Year:  2016        PMID: 27411685     DOI: 10.1007/s00105-016-3851-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  21 in total

1.  Sub6 (Tri r 2), an Onychomycosis Marker Revealed by Proteomics Analysis of Trichophyton rubrum Secreted Proteins in Patient Nail Samples.

Authors:  Bruno Méhul; Zhengzheng Gu; André Jomard; Gilbert Laffet; Martine Feuilhade; Michel Monod
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551

Review 2.  Dermatomycoses and inflammation: The adaptive balance between growth, damage, and survival.

Authors:  B Hube; R Hay; J Brasch; S Veraldi; M Schaller
Journal:  J Mycol Med       Date:  2015-02-07       Impact factor: 2.391

3.  [Contact sensitization to azole antimycotics].

Authors:  R Brans; M Wosnitza; J M Baron; H F Merk
Journal:  Hautarzt       Date:  2009-05       Impact factor: 0.751

4.  Contact allergy to topical antifungal agents.

Authors:  C A Menezes de Pádua; W Uter; J Geier; A Schnuch; I Effendy
Journal:  Allergy       Date:  2008-07       Impact factor: 13.146

5.  [Significance of therapy planning].

Authors:  J Wohlrab
Journal:  Hautarzt       Date:  2014-03       Impact factor: 0.751

6.  Miconazole, a broad-spectrum antimycotic agent with antibacterial activity.

Authors:  J M Van Cutsem; D Thienpont
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

7.  Female exposure to phenols and phthalates and time to pregnancy: the Maternal-Infant Research on Environmental Chemicals (MIREC) Study.

Authors:  Maria P Vélez; Tye E Arbuckle; William D Fraser
Journal:  Fertil Steril       Date:  2015-02-11       Impact factor: 7.329

8.  Double-blind comparison of miconazole/corticosteroid combination versus miconazole in inflammatory dermatomycoses.

Authors:  S Nolting; K Rogalla
Journal:  Int J Dermatol       Date:  1995-02       Impact factor: 2.736

9.  [The influence of steroids on the antifungal and antibacterial activities of imidazole derivatives (author's transl)].

Authors:  F Högl; W Raab
Journal:  Mykosen       Date:  1980-08

Review 10.  Efficacy of triclosan as an antimicrobial hand soap and its potential impact on antimicrobial resistance: a focused review.

Authors:  Christopher A Giuliano; Michael J Rybak
Journal:  Pharmacotherapy       Date:  2015-03       Impact factor: 4.705

View more
  1 in total

Review 1.  [Dermatophyte : Current situation].

Authors:  P Mayser
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.